Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

A simple pill for meth addicts on the cards

Researchers from Australia's Curtin University have developed a simple pill that could be used to treat methamphetamine addicts. It would soon be tried in a clinical trial to prove its efficacy and utility said the researchers.

18 Jul 2018

Novel delivery system for bacteriophages could offer new way to battle lung infections

A new delivery system for bacteriophages - viruses that selectively attack harmful bacteria - could help give doctors a new way to battle lung infections that threaten older patients and people with cystic fibrosis.

17 Jul 2018

Component of cinnamon oil can help treat certain bacterial infections

Researchers have found that a major component of cinnamon oil can help to clear certain bacterial infections.

12 Jul 2018

Bacteria adapted to the human body may become more susceptible to antibiotics

A new study published today in Nature Communications, led by scientists at the University of Liverpool in collaboration with the University of Salford, finds evidence that as bacteria adapt to the human body, they can sometimes become more susceptible to antibiotics and therefore easier to kill.

6 Jul 2018

Antioxidant-enriched vitamin may decrease exacerbations in cystic fibrosis patients

An antioxidant-enriched vitamin may decrease respiratory exacerbations in people with cystic fibrosis(CF), according to new research published online in April in the American Journal of Respiratory and Critical Care Medicine.

2 Jul 2018

Study finds that several existing anti-cancer drugs may work in part by binding to RNA

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.

30 Jun 2018

Children's Colorado participates in cystic fibrosis triple combination therapy trials

Children's Hospital Colorado has announced that its Mike McMorris Cystic Fibrosis Research and Care Center, one of the largest cystic fibrosis clinical care centers in the U.S., is participating in one of two Phase Three clinical trials related to the development of a possible breakthrough therapy for people with CF.

29 Jun 2018

Researchers identify novel mutation in amyloid diseases

Researchers have identified a one-of-a kind mutation in the DNA of a patient who died of transthyretin (TTR) amyloidosis, a progressive condition characterized by the buildup of abnormal deposits of a misfolded protein called amyloid in the body's organs and tissues.

26 Jun 2018

Researchers work on new treatment that could improve lives of cystic fibrosis patients

Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients.

25 Jun 2018

UC San Diego launches new bacteriophage therapy center

With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in collaboration with national research institutions and private industry, are leveraging hard-won expertise to exploit a natural viral enemy of pathogenic bacteria, creating North America's first Center for Innovative Phage Applications and Therapeutics

22 Jun 2018

MAARA to celebrate its 50th anniversary with lecture titled 'The Future of Asthma'

50 years of pioneering asthma research which has benefited patients and sufferers throughout the UK will be celebrated at an event hosted by the University of Leicester on Wednesday 20 June.

19 Jun 2018

WVU researcher aims to produce updated whooping cough vaccine

Before the whooping-cough vaccine came into widespread use in the 1940s, about 9,000 American children died from the infection each year. Today, thanks to the vaccine's efficacy, reported cases of whooping cough have dramatically declined and fatalities have dropped to up to 20 children each year.

18 Jun 2018

Award granted to Neem Biotech to develop antimicrobial intervention for chronic lung infections

Neem are working on a novel approach to antimicrobial resistance, which involves preventing the formation of and disrupts mature biofilms that are produced by bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus.

From Neem Biotech 18 Jun 2018

Translate Bio collaborates with Sanofi to develop mRNA vaccines for infectious diseases

Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.

11 Jun 2018

Mucus appears to protect flu virus when it becomes airborne, shows study

Mucus and other airway secretions that are expelled when a person with the flu coughs or exhales appear to protect the virus when it becomes airborne, regardless of humidity levels, a creative experiment conducted by the University of Pittsburgh and Virginia Tech discovered.

7 Jun 2018

Antimicrobial peptides are promising alternative for combatting antimicrobial resistance

Overuse of antibiotics has led to the spread of multi-resistant bacteria that do not respond to conventional treatments.

29 May 2018

Antioxidant-enriched multivitamin may decrease respiratory illnesses in CF patients, finds study

Researchers at Children's Hospital Colorado and the University of Colorado School of Medicine have found that taking a specially formulated antioxidant-enriched multivitamin may decrease respiratory illnesses in people with cystic fibrosis.

24 May 2018

Antibacterial substance found in toothpaste may fight against life-threatening lung disease

Michigan State University researchers have found that when triclosan, a substance that reduces or prevents bacteria from growing, is combined with an antibiotic called tobramycin, it kills the cells that protect the CF bacteria, known as Pseudomonas aeruginosa, by up to 99.9 percent.

17 May 2018

CU Anschutz Medical Campus receives NIH grant to speed up discovery of new treatments

The National Institutes of Health recently awarded $46.5 million to the University of Colorado Anschutz Medical Campus and its Colorado Clinical and Translational Sciences Institute, a research partnership designed to speed up development of new treatments to address the greatest health needs of Coloradans.

25 Apr 2018

Researchers discover genetic catalysts that accelerate evolution of antibiotic resistance in bacteria

Researchers at Oxford University have shown that it is possible to identify genetic catalysts that accelerate the evolution of antibiotic resistance in bacteria - and that this knowledge could be used to design treatments to stifle the development of resistance.

24 Apr 2018

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

A simple pill for meth addicts on the cards

Novel delivery system for bacteriophages could offer new way to battle lung infections

Component of cinnamon oil can help treat certain bacterial infections

Bacteria adapted to the human body may become more susceptible to antibiotics

Antioxidant-enriched vitamin may decrease exacerbations in cystic fibrosis patients

Study finds that several existing anti-cancer drugs may work in part by binding to RNA

Children's Colorado participates in cystic fibrosis triple combination therapy trials

Researchers identify novel mutation in amyloid diseases

Researchers work on new treatment that could improve lives of cystic fibrosis patients

UC San Diego launches new bacteriophage therapy center

MAARA to celebrate its 50th anniversary with lecture titled 'The Future of Asthma'

WVU researcher aims to produce updated whooping cough vaccine

Award granted to Neem Biotech to develop antimicrobial intervention for chronic lung infections

Translate Bio collaborates with Sanofi to develop mRNA vaccines for infectious diseases

Mucus appears to protect flu virus when it becomes airborne, shows study

Antimicrobial peptides are promising alternative for combatting antimicrobial resistance

Antioxidant-enriched multivitamin may decrease respiratory illnesses in CF patients, finds study

Antibacterial substance found in toothpaste may fight against life-threatening lung disease

CU Anschutz Medical Campus receives NIH grant to speed up discovery of new treatments

Researchers discover genetic catalysts that accelerate evolution of antibiotic resistance in bacteria

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in